Wells Fargo’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Sell
42,260
-56,246
-57% -$2.08M ﹤0.01% 3549
2025
Q4
$4.15M Buy
98,506
+41,735
+74% +$1.68M ﹤0.01% 2853
2025
Q3
$1.95M Buy
56,771
+8,778
+18% +$252K ﹤0.01% 3326
2025
Q2
$1.3M Sell
47,993
-6,187
-11% -$179K ﹤0.01% 3523
2025
Q1
$1.61M Buy
54,180
+3,049
+6% +$116K ﹤0.01% 3338
2024
Q4
$2.02M Buy
51,131
+11,387
+29% +$431K ﹤0.01% 3194
2024
Q3
$1.35M Sell
39,744
-53,315
-57% -$1.5M ﹤0.01% 3345
2024
Q2
$2.02M Sell
93,059
-3,316
-3% -$69.7K ﹤0.01% 2973
2024
Q1
$2.14M Buy
96,375
+14,115
+17% +$344K ﹤0.01% 2920
2023
Q4
$2.26M Sell
82,260
-33,334
-29% -$805K ﹤0.01% 2811
2023
Q3
$2.58M Sell
115,594
-16,867
-13% -$434K ﹤0.01% 2606
2023
Q2
$3.37M Buy
132,461
+7,203
+6% +$175K ﹤0.01% 2474
2023
Q1
$2.79M Buy
125,258
+60,007
+92% +$1.45M ﹤0.01% 2585
2022
Q4
$1.55M Sell
65,251
-6,773
-9% -$157K ﹤0.01% 2963
2022
Q3
$1.2M Sell
72,024
-4,141
-5% -$93.2K ﹤0.01% 3118
2022
Q2
$1.52M Sell
76,165
-49,124
-39% -$992K ﹤0.01% 3001
2022
Q1
$3.45M Sell
125,289
-12,376
-9% -$354K ﹤0.01% 2777
2021
Q4
$5.67M Sell
137,665
-53,135
-28% -$2.35M ﹤0.01% 2441
2021
Q3
$8.86M Buy
190,800
+1,953
+1% +$85.2K ﹤0.01% 2318
2021
Q2
$7.55M Sell
188,847
-18,779
-9% -$803K ﹤0.01% 2467
2021
Q1
$11.2M Buy
207,626
+13,729
+7% +$791K ﹤0.01% 2110
2020
Q4
$9.49M Sell
193,897
-40,612
-17% -$1.88M ﹤0.01% 2121
2020
Q3
$7.62M Sell
234,509
-7,557
-3% -$240K ﹤0.01% 2112
2020
Q2
$6.27M Buy
242,066
+9,460
+4% +$236K ﹤0.01% 2256
2020
Q1
$5.66M Sell
232,606
-29,012
-11% -$730K ﹤0.01% 2135
2019
Q4
$7.3M Sell
261,618
-120,029
-31% -$3.11M ﹤0.01% 2238
2019
Q3
$9.16M Buy
381,647
+30,950
+9% +$823K ﹤0.01% 2004
2019
Q2
$10M Buy
350,697
+184,597
+111% +$4.61M ﹤0.01% 1964
2019
Q1
$4.16M Buy
166,100
+84,153
+103% +$1.61M ﹤0.01% 2730
2018
Q4
$1.03M Buy
81,947
+38,598
+89% +$456K ﹤0.01% 3827
2018
Q3
$415K Buy
43,349
+5,885
+16% +$64.9K ﹤0.01% 4568
2018
Q2
$349K Buy
37,464
+3,881
+12% +$27.3K ﹤0.01% 4711
2018
Q1
$187K Buy
33,583
+228
+0.7% +$1.41K ﹤0.01% 5019
2017
Q4
$218K Buy
33,355
+5,700
+21% +$42.4K ﹤0.01% 4920
2017
Q3
$243K Buy
27,655
+8,903
+47% +$72.4K ﹤0.01% 4822
2017
Q2
$156K Hold
18,752
﹤0.01% 4937
2017
Q1
$172K Buy
18,752
+9,938
+113% +$81.3K ﹤0.01% 4901
2016
Q4
$68K Buy
8,814
+362
+4% +$2.71K ﹤0.01% 5295
2016
Q3
$64K Hold
8,452
﹤0.01% 5173
2016
Q2
$43K Buy
8,452
+7,554
+841% +$40.5K ﹤0.01% 5259
2016
Q1
$4K Buy
898
+820
+1,051% +$4.85K ﹤0.01% 5920
2015
Q4
$1K Sell
78
-2,749
-97% -$18.5K ﹤0.01% 6117
2015
Q3
$13K Buy
2,827
+2,152
+319% +$20.5K ﹤0.01% 5659
2015
Q2
$8K Buy
675
+354
+110% +$3.48K ﹤0.01% 5880
2015
Q1
$2K Buy
321
+20
+7% +$164 ﹤0.01% 5984
2014
Q4
$3K Sell
301
-755,235
-100% -$5.89M ﹤0.01% 5966
2014
Q3
$7.37M Sell
755,536
-122,999
-14% -$1.61M ﹤0.01% 2007
2014
Q2
$15M Buy
878,535
+17,942
+2% +$258K 0.01% 1496
2014
Q1
$14.7M Buy
860,593
+58,603
+7% +$936K 0.01% 1481
2013
Q4
$11.6M Buy
+801,990
New +$10.4M 0.01% 1613

Other funds holding VCYT

Wells Fargo's VCYT Position: Q1 2026 in Review

Wells Fargo reduced its Veracyte (VCYT) stake by 57% in Q1 2026, selling an estimated $2.08M and leaving 42,260 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3549.

Wells Fargo first reported a position in VCYT in Q4 2013 and has held it in 50 quarters since. The position peaked at $15M in Q2 2014. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Wells Fargo held 42,260 shares of Veracyte worth $1.36M as of Q1 2026.
  • Wells Fargo sold 56,246 Veracyte shares in Q1 2026, an estimated $2.08M.
  • Veracyte made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3549 holding.
  • Wells Fargo first reported a position in Veracyte in Q4 2013 and has held it in 50 quarters since.
  • Wells Fargo's Veracyte position peaked at $15M in Q2 2014.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.